Skip to main content
. 2016 Jan 1;8(1):e2016004. doi: 10.4084/MJHID.2016.004

Table 1.

Clinical characteristics, laboratory parameters and GSTP1 analysis of studied groups.

Variable Patients (n=35) Control (n=30) P-value
Age (years) 13.7±3.3 14.3±2.6 0.43
Sex male, n (%) 23(65.7) 15(50) 0.22
Weight (Kg) 36.22±10.82 57.46±12.34 <0.0001
Weight for age Z- score(WAZ) −1.5±0.67 0.78±0.36 <0.0001
Height (Cm) 142.06±14.6 156.6±11.28 0.001
Height for age Z- score(HAZ) −1.25±0.87 −0.033±0.26 <0.0001
BMI 17.9±3.8 23.1±2.5 <0.0001
BMI for age Z- score −1.25±0.87 −0.033±0.26 <0.0001
Puberty, n (%)
 Normal 15(42.9) 30(100) <0.0001
 Delayed 20(57.1) 0(0.0)
Hb (gm/dl ) 7.6±0.52 12.82±0.67 <0.0001
ALT (U/l) 41.17±29.82 16.33±0.64 <0.0001
AST (U/l) 42.57±32.53 27.54±3.67 0.727
Blood urea (mg/dl) 16.71±3.43 16.67±3.03 0.95
Serum creatinine (mg/dl) 0.52±0.12 0.55±0.15 0.33
Serum Ca ( mg/dl) 9.21±0.7 9.52±0.37 0.09
Serum Ph ( mg/dl) 3.02±0.45 2.82±0.49 0.1
TALP (U/l) 764.03±75.03 94.27±20.35 <0.0001
Serum Ferritin (ng/ml ) 3329.6±2707.7 99.67±16.28 <0.0001
Osteocalcin ( ng/ml) 13.07±2.87 4.63±1.13 <0.0001
BMD -LS (gm/cm2) 0.57±0.20 1.53±0.47 <0.0001
Z - score -LS −3.42±1.04 1.23±0.76 <0.0001
BMD haz Z- LS −2.34±1.19 1.35±0.7 <0.0001
BMD -FN (gm/cm2) 0.59±0.21 1.54±0.46 <0.0001
Z- score -FN −2.39±0.96 1.24±0.72 <0.0001
BMDhaz Z- FN −1.67±0.96 1.35±0.75 <0.0001
Allele frequency
A 0.49 0.87 <0.0001
G 0.51 0.13
Ile 105 Val allele, n (%)
Polymorphic (G allele ) 27(77.1) 6(20) <0.0001
Non-polymorphic (A allele ) 8(22.9) 24(80)
Ile 105 Val genotype, n (%)
Wild homozygotes (AA) 8 (22.9) 24 (80) <0.0001
Heterozygotes (AG) 18 (51.4) 4 (13.3) 0.001
Homozygotes (GG) 9 (25.7) 2 (6.7) 0.04

BMI; body mass index; Hb; hemoglobin; ALT; alanine aminotransferase; AST; aspartate aminotransferase; Ca; calcium; Ph; phosphorous; TALK; total alkaline phosphatase; BMD; bone mineral density; LS; lumbar spine; FN; femoral neck.